Palantir Technologies (PLTR) and AI-driven growth
Palantir Technologies Inc (NYSE:PLTR), a leader in data analytics and defense software, sees significant growth in both business expansion and capital markets through 2025. Growth is driven primarily by developments in artificial intelligence (AI), defense contracts, and innovations within the Foundry platform. Financials and Stock Performance Shares of Palantir reached a price of $139.96 as […]
Eli Lilly and strategic acquisitions
Eli Lilly & Co. (NYSE:LLY), a global leader in pharmaceuticals and biotechnology, continues to strengthen its position in innovative therapeutic areas. In recent weeks, it has made several key moves impacting its strategic development, stock market and regulatory environment. 1. Acquisition of Verve Therapeutics for $1.3 billion Eli Lilly announced that it has entered into […]
Eli Lilly and strategic acquisitions
Eli Lilly & Co. (NYSE:LLY), a global leader in pharmaceuticals and biotechnology, continues to strengthen its position in innovative therapeutic areas. In recent weeks, it has made several key moves impacting its strategic development, stock market and regulatory environment. 1. Acquisition of Verve Therapeutics for $1.3 billion Eli Lilly announced that it has entered into […]